Researcher.Life Logo

Experimental and Molecular Medicine : Impact Factor & More

eISSN: 2092-6413pISSN: 1226-3613
JournalOpen Access

Key Metrics

CiteScore
15.6
Eigenfactor
0.01 - 0.05
H-Index
104
Impact Factor
10 - 15
SJR
Q1Biochemistry
SNIP
2.26
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Experimental and Molecular Medicine

Experimental and Molecular Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Monthly
Article Processing ChargesEUR 3690 | USD 4290 | GBP 3090
Publication Time5
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorKorean Society of Biochemistry and Molecular Biology
FrequencyMonthly
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 5
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Experimental and Molecular Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Experimental and Molecular Medicine

MeCP2 regulates cell-type-specific functions of depressive-like symptoms in the nucleus accumbens.
  • 12 May 2026
  • Experimental & molecular medicine
Cannabidiol triggers fatty acids β-oxidation mediated by Stat2 to facilitate intestinal stem cells regeneration post radiation.
  • 12 May 2026
  • Experimental & molecular medicine
Author Correction: Curing the brain: in search for new astrocyte-specific therapies.
  • 11 May 2026
  • Experimental & molecular medicine
De novo and scaffold-based design of GDF15 binders for cancer cachexia diagnostics and therapeutics.
  • 8 May 2026
  • Experimental & molecular medicine
N-terminal formylmethionine as a degron and a specific signal in proteostasis and stress adaptation.
  • 8 May 2026
  • Experimental & molecular medicine
Hepatocyte estrogen-related receptor α modulates a gluconeogenic-epigenetic crosstalk counteracting MASLD/MASH progression.
  • 8 May 2026
  • Experimental & molecular medicine
MeCP2 regulates cell-type-specific functions of depressive-like symptoms in the nucleus accumbens.
  • 12 May 2026
  • Experimental & molecular medicine
Cannabidiol triggers fatty acids β-oxidation mediated by Stat2 to facilitate intestinal stem cells regeneration post radiation.
  • 12 May 2026
  • Experimental & molecular medicine
Author Correction: Curing the brain: in search for new astrocyte-specific therapies.
  • 11 May 2026
  • Experimental & molecular medicine
De novo and scaffold-based design of GDF15 binders for cancer cachexia diagnostics and therapeutics.
  • 8 May 2026
  • Experimental & molecular medicine
N-terminal formylmethionine as a degron and a specific signal in proteostasis and stress adaptation.
  • 8 May 2026
  • Experimental & molecular medicine
Hepatocyte estrogen-related receptor α modulates a gluconeogenic-epigenetic crosstalk counteracting MASLD/MASH progression.
  • 8 May 2026
  • Experimental & molecular medicine

FAQs on Experimental and Molecular Medicine